Re:Conclusions from analyzing Y Combinator’s investing history
by ekianjo on Friday December 27, 2019 @07:04PM
(#21895998)
> cancer research still has to ask for donation at local grocery store.
Erm no. Cancer Research has been booming in investment for at least the past 15 years. I will let you ponder on this:
> "Oncology is the area with the largest proportion of clinical development spending with 40% of total pipeline expenditure, with close to 20% market share of pharma sales in 2024"
Erm no. Cancer Research has been booming in investment for at least the past 15 years. I will let you ponder on this:
> "Oncology is the area with the largest proportion of clinical development spending with 40% of total pipeline expenditure, with close to 20% market share of pharma sales in 2024"
https://www.evaluate.com/sites/default/files/media/download-...
Also, some of the biggest M&A in Pharma in the recent years have been about Cancer Research and Treatments. A few examples:
- Shire taking over Baxalta.
- BMS taking over Celgene
- Roche taking over Genentech
- Abbvie taking over Pharmacyclics
And there's more coming...